Eyevensys S.A.S.

Biotechnology company · Paris, Île-de-France, France

Eyevensys S.A.S. is a biotechnology company headquartered in Paris, Île-de-France, France. Its earliest recorded incorporation is in 2018. It has reported private securities offerings to the US SEC, most recently $10 million sold in a notice filed in 2021.

Profile compiled from public records. Is this your company? Request a correction or update

Eyevensys S.A.S. at a glance

Typebiotechnology company

HeadquartersParis, Île-de-France, France

Earliest incorporation on record2018

SEC CIK1884944

What does Eyevensys S.A.S. do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $10 million sold (2021).

Frequently asked questions about Eyevensys S.A.S.

Where is Eyevensys S.A.S. headquartered?

Eyevensys S.A.S. is headquartered in Paris, Île-de-France, France.

What does Eyevensys S.A.S. do?

Eyevensys S.A.S. is a biotechnology company.

When was Eyevensys S.A.S. founded?

The earliest incorporation on record for Eyevensys S.A.S. is in 2018, according to public company registers.

Similar companies

Gensight Biologics S.A.Paris, Île-de-France, France
Cellectis S.A.Paris, Île-de-France, France
AB Science S.A.Paris, Île-de-France, France
DBV Technologies S.A.Châtillon, Île-de-France, France
Innate Pharma SAMarseille, Provence-Alpes-Côte d'Azur, France
PHAXIAM Therapeutics S.A.Lyon, Auvergne-Rhône-Alpes, France
Genfit S.A.Loos, Hauts-de-France, France
Cerenis Therapeutics Holding S.A.Labège, Occitanie, France

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences